René Galien
- Oncology top 10%
- Rheumatology top 5%
- Genetics top 5%
- Immunology
- Hematology top 10%
- Co-authors
- Bernard P. MurrayJulie A. Di PaoloFederico CampigottoAmy MengPaqui G. TravésGerben van ‘t KloosterAnnegret Van der AaReginald Brys
- Topics
- Cytokine Signaling Pathways and Interactions (16 papers)Inflammatory Bowel Disease (9 papers)Rheumatoid Arthritis Research and Therapies (8 papers)
- Cited by
- RheumatologyGeneticsHematology
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
René Galien
30 papers receiving 692 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 308
- Rheumatology 290
- Genetics 174
- Immunology 159
- Hematology 133
Countries citing papers authored by René Galien
This map shows the geographic impact of René Galien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Galien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Galien more than expected).
Fields of papers citing papers by René Galien
This network shows the impact of papers produced by René Galien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Galien. The network helps show where René Galien may publish in the future.
Co-authorship network of co-authors of René Galien
This figure shows the co-authorship network connecting the top 25 collaborators of René Galien. A scholar is included among the top collaborators of René Galien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Galien. René Galien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinibbreakdown → | 218 |
| 8 | 27 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 61 | |
| 14 | 47 | |
| 15 | 20 | |
| 16 | GPR84 inhibition as a novel therapeutic approach in IBD: mechanistic and translational studies | 1 |
| 17 | 6 | |
| 18 | 1 | |
| 19 | 181 | |
| 20 | 0 |
About René Galien
René Galien is a scholar working on Rheumatology, Genetics and Oncology, having authored 32 papers that have together received 706 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (16 papers), Inflammatory Bowel Disease (9 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). The work is most often cited by research in Rheumatology (290 citations), Genetics (174 citations) and Hematology (133 citations). René Galien has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Bernard P. Murray, Julie A. Di Paolo, Federico Campigotto, Amy Meng, Paqui G. Través, Gerben van ‘t Klooster, Annegret Van der Aa, Reginald Brys, Ellen M. van der Aar and L Nelles. Their work appears in journals such as The Journal of Immunology, Gastroenterology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.